Malignant gliomas induce and exploit astrocytic mesenchymal-like transition by activating canonical Wnt/β-catenin signaling

Medical Oncology

Volumn 33, Issue 7, 2016, Pages

  Lu, Ping ^a   Wang, Yajing ^a   Liu, Xiuting ^a   Wang, Hong ^a   Zhang, Xin ^a   Wang, Kequan ^a   Wang, Qing ^b   Hu, Rong ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b WUXI NO 2 PEOPLE S HOSPITAL   (China)

Author keywords

GFAP; Malignant glioma; PDPN; Tumor microenvironment; Tumor associated astrocytes (TAAs); Wnt catenin signaling

Indexed keywords

BETA CATENIN; MATRIX METALLOPROTEINASE; UVOMORULIN; VIMENTIN; WNT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; GLIOBLASTOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; ANIMAL; BRAIN TUMOR; C57BL MOUSE; CELL CULTURE; FLUORESCENT ANTIBODY TECHNIQUE; GLIOMA; IMMUNOHISTOCHEMISTRY; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TUMOR CELL LINE; TUMOR INVASION; WESTERN BLOTTING; WNT SIGNALING PATHWAY;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELLS, CULTURED; EPITHELIAL-MESENCHYMAL TRANSITION; FLUORESCENT ANTIBODY TECHNIQUE; GLIOMA; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR MICROENVIRONMENT; WNT SIGNALING PATHWAY;

EID: 84971377492     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-016-0778-0     Document Type: Article

References (33)

1. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med. 2008;359:492–507.
2. Placone AL, Quinones-Hinojosa A, Searson PC. The role of astrocytes in the progression of brain cancer: complicating the picture of the tumor microenvironment. Tumour Biol. 2016;37:61–9.
3. Holland EC. Glioblastoma multiforme: the terminator. Proc Natl Acad Sci USA. 2000;97(12):6242–4.
4. Hu M, Polyak K. Microenvironmental regulation of cancer development. Curr Opin Genet Dev. 2008;18(1):27–34.
5. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer. 2009;9(4):239–52.
6. Charles NA, et al. The brain tumor microenvironment. Glia. 2011;59(8):1169–80.
7. Pekny M, Pekna M. Astrocyte intermediate filaments in CNS pathologies and regeneration. J Pathol. 2004;204(4):428–37.
8. Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 2010;119(1):7–35.
9. Pekny M, Wilhelmsson U, Pekna M. The dual role of astrocyte activation and reactive gliosis. Neurosci Lett. 2014;565:30–8.
10. Chen W, et al. Glioma cells escaped from cytotoxicity of temozolomide and vincristine by communicating with human astrocytes. Med Oncol. 2015;32(3):43.
11. Chuang HN, et al. Carcinoma cells misuse the host tissue damage response to invade the brain. Glia. 2013;61(8):1331–46.
12. Kolar K, et al. Podoplanin: a marker for reactive gliosis in gliomas and brain injury. J Neuropathol Exp Neurol. 2015;74(1):64–74.
13. Mishima K, et al. Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression. Acta Neuropathol. 2006;111(5):483–8.
14. Seike T, et al. Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis. Clin Exp Metastasis. 2011;28(1):13–25.
15. Shabtay-Orbach A, et al. Paracrine regulation of glioma cells invasion by astrocytes is mediated by glial-derived neurotrophic factor. Int J Cancer. 2015;137(5):1012–20.
16. Klein A, et al. Astrocytes facilitate melanoma brain metastasis via secretion of IL-23. J Pathol. 2015;236(1):116–27.
17. Sin WC, et al. Astrocytes promote glioma invasion via the gap junction protein connexin43. Oncogene. 2016;35:12:1504–16.
18. Wang L, et al. Astrocytes directly influence tumor cell invasion and metastasis in vivo. PLoS ONE. 2013;8(12):e80933.
19. Kim DY, Jeoung D, Ro JY. Signaling pathways in the activation of mast cells cocultured with astrocytes and colocalization of both cells in experimental allergic encephalomyelitis. J Immunol. 2010;185(1):273–83.
20. Kahlert UD, et al. Activation of canonical WNT/beta-catenin signaling enhances in vitro motility of glioblastoma cells by activation of ZEB1 and other activators of epithelial-to-mesenchymal transition. Cancer Lett. 2012;325(1):42–53.
21. Ferrer-Vaquer A, et al. A sensitive and bright single-cell resolution live imaging reporter of Wnt/ss-catenin signaling in the mouse. BMC Dev Biol. 2010;10:121.
22. Hol EM, Pekny M. Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr Opin Cell Biol. 2015;32:121–30.
23. Fitzgerald DP, et al. Reactive glia are recruited by highly proliferative brain metastases of breast cancer and promote tumor cell colonization. Clin Exp Metastasis. 2008;25(7):799–810.
24. Lee J, et al. Non-invasive quantification of brain tumor-induced astrogliosis. BMC Neurosci. 2011;12:9.
25. Ridet JL, et al. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 1997;20(12):570–7.
26. Shindo K, et al. Podoplanin expression in cancer-associated fibroblasts enhances tumor progression of invasive ductal carcinoma of the pancreas. Mol Cancer. 2013;12(1):168.
27. Astarita JL, Acton SE, Turley SJ. Podoplanin: emerging functions in development, the immune system, and cancer. Front Immunol. 2012;3:283.
28. Kahlert UD, Nikkhah G, Maciaczyk J. Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas. Cancer Lett. 2013;331(2):131–8.
29. Zhang K, et al. Wnt/beta-catenin signaling in glioma. J Neuroimmune Pharmacol. 2012;7(4):740–9.
30. Satoh J, Kuroda Y. Beta-catenin expression in human neural cell lines following exposure to cytokines and growth factors. Neuropathology. 2000;20(2):113–23.
31. Zhao P, et al. GSK-3beta regulates tumor growth and angiogenesis in human glioma cells. Oncotarget. 2015;6(31):31901–15.
32. Venning FA, Wullkopf L, Erler JT. Targeting ECM disrupts cancer progression. Front Oncol. 2015;5:224.
33. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141(1):52–67.